232 results on '"Mrus, Joseph"'
Search Results
2. Health Values of Patients Coinfected with HIV/Hepatitis C: Are Two Viruses Worse Than One?
3. Gender Differences in Health-Related Quality of Life in Patients with HIV/AIDS
4. Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
5. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
6. Editorial Commentary: Getting beyond Diagnostic Accuracy: Moving toward Approaches That Can Be Used in Practice
7. Variations in Self-Rated Health among Patients with HIV Infection
8. Change in quality of life after being diagnosed with HIV: a multicenter longitudinal study
9. Development of an electronic medical record-based clinical decision support tool to improve HIV symptom management
10. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084
11. Patterns of responses on health-related quality of life questionnaires among patients with HIV/AIDS
12. Religion, spirituality, and depressive symptoms in patients with HIV/AIDS
13. How do patients with HIV/AIDS understand and respond to health value questions?
14. Spirituality and religion in patients with HIV/AIDS
15. Modeling the effects of spirituality/religion on patients’ perceptions of living with HIV/AIDS
16. Health-related quality of life in veterans and nonveterans with HIV/AIDS
17. Insights on GRACE (Gender, Race, And Clinical Experience) from the Patientʼs Perspective:GRACE Participant Survey
18. Factors predictive of anemia development in treatment^ experienced patients receiving telaprevir (T; TVR) plus peginterferon/ribavirin (PR) in the REALIZE trial: 771
19. Development of an HIV research database using Medicaid claims data
20. Effects of Darunavir/Ritonavir-Based Therapy on Metabolic and Anthropometric Parameters in Women and Men Over 48 Weeks
21. Pharmacoeconomics of darunavir
22. 1704. Regional and Racial Disparities in Response to Antiretroviral Therapy (ART) among People Living with Human Immunodeficiency Virus (PLWH)
23. Real-World Experience with Dolutegravir-Based Two-Drug Regimens
24. Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
25. Pharmacoeconomics of etravirine
26. Sex-Based Outcomes of Darunavir–Ritonavir Therapy: A Single-Group Trial
27. Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study
28. Comparative Cost-Efficacy Analysis of Darunavir/ritonavir and Other Ritonavir-Boosted Protease Inhibitors for First-Line Treatment of HIV-1 Infection in the United States
29. Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study
30. Biochemical and Virologic Parameters in Patients Co-Infected with Hepatitis C and HIV Versus Patients with Hepatitis C Mono-Infection
31. IMPORTANCE OF ORGAN DYSFUNCTION IN DETERMINING HOSPITAL OUTCOMES IN CHILDREN
32. Evaluating Adolescents in Juvenile Detention Facilities for Urogenital Chlamydial Infection: Costs and Effectiveness of Alternative Interventions
33. Evaluation of heart murmurs in children: Cost-effectiveness and practical implications
34. The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy
35. 884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies
36. 2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen
37. Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study
38. Getting beyond diagnostic accuracy: moving toward approaches that can be used in practice
39. Self-rated health of primary care house officers and its relationship to psychological and spiritual well-being
40. Gender differences in health-related quality of life of adolescents with cystic fibrosis
41. Do medical house officers value the health of veterans differently from the health of non-veterans?
42. Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study
43. Spirituality and Religion in Patients with HIV/AIDS
44. Impact of HIV/AIDS on care and outcomes of severe sepsis
45. Darunavir, Ritonavir, and Etravirine Pharmacokinetics in the Cervicovaginal Fluid and Blood Plasma of HIV-Infected Women
46. Sex-Based Outcomes of Darunavir–Ritonavir Therapy: The GRACE (Gender, Race, and Clinical Experience) Study
47. Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients
48. Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy
49. Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study.
50. Health-related quality of life in the gender, race, and clinical experience trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.